|
|
Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study
C. Biron
,
P. Seksik
,
M. Nachury
,
S. Nancey
,
Y. Bouhnik
,
et al.
Communication dans un congrès
hal-03552294v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study
A. Amiot
,
M. Serrero
,
L. Peyrin-Biroulet
,
J. Filippi
,
B. Pariente
,
et al.
Communication dans un congrès
hal-03552293v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
L. Lair-Mehiri
,
C. Stefanescu
,
T. Vaysse
,
D. Laharie
,
X. Roblin
,
et al.
Article dans une revue
hal-03552302v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of ustekinumab in perianal Crohn's disease: the BioLAP multi-centre observational study
C. Biron
,
P. Seksik
,
M. Nachury
,
Y. Bouhnik
,
A. Amiot
,
et al.
Communication dans un congrès
hal-03552295v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience
Pauline Wils
,
Yoram Bouhnik
,
Pierre Michetti
,
Bernard Flourie
,
Hédia Brixi
,
et al.
12. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2017, Barcelone, Spain
Communication dans un congrès
hal-03553341v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|